Breaking News Instant updates and real-time market news.

TSRO

TESARO

$145.90

-1.34 (-0.91%)

05:28
01/12/17
01/12
05:28
01/12/17
05:28

TESARO receives CRL from FDA for rolapitant IV NDA

TESARO announced that the FDA has issued a Complete Response Letter, or CRL, regarding the rolapitant IV New Drug Application, or NDA, for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy. FDA requested additional information regarding the in vitro method utilized to demonstrate comparability of drug product produced at the two proposed commercial manufacturers for rolapitant IV that were included in the NDA. TESARO is working expeditiously to provide the requested information. The CRL did not identify concerns related to the safety or efficacy of rolapitant IV or request additional clinical studies. No concerns were raised regarding the active pharmaceutical ingredient, which is also used for the Varub oral product. TESARO identified potential deficiencies at the original contract manufacturer for rolapitant IV drug product, secured a second drug product supplier and included data from this manufacturer in the NDA. During the NDA review, FDA requested and TESARO provided in vitro data to demonstrate comparability of drug product made at the two manufacturing sites.

  • 30

    Jun

TSRO TESARO
$145.90

-1.34 (-0.91%)

12/27/16
FBRC
12/27/16
NO CHANGE
Target $151
FBRC
Outperform
FBR Capital ups TESARO price target to $151
FBR Capital analyst Ed White raised his price target for TESARO to $151 from $133 and keeps the Outperform rating on the shares. The oncology-focused biopharmaceutical company closed Friday up $7.27 to $139.86. TESARO recently announced that the FDA has granted Priority Review for niraparib with a June 30, 2017 action date, White tells investors in a research note. He believes niraparib could be a potential blockbuster PARP inhibitor. Meanwhile, the launch of Varubi continues to "ramp up," with sequential quarter-over-quarter unit growth of 14%, the analyst writes. White says the drug achieved a 28% share of the oral NK-1 market in the U.S. in September.
01/04/17
GABE
01/04/17
NO CHANGE
GABE
Gabelli sees Incyte as more likely target following Gilead hire
Gilead (GILD) is more likely to buy Incyte (INCY) after naming Alessandro Riva to head its Hematology and Oncology Therapeutic unit, Gabelli analyst Jing He tells investors in a research note. Dr. Riva is a Novartis (NVS) veteran while Incyte is led by a team of Novartis veterans and has collaborated with Novartis Oncology on its key drug, Jakafi, the analyst points out. He believes Incyte is "big enough to move the needle" and bring long term growth to Gilead. The analyst lists Seattle Genetics (SGEN) and TESARO (TSRO) as other potential targets for the biotech giant. He believes Incyte is the "best fit."
01/09/17
LEER
01/09/17
NO CHANGE
Target $152
LEER
Outperform
TESARO price target raised to $152 from $115 at Leerink
Leerink analyst Seamus Fernandez raised his price target for TESARO to $152 from $115 to fully incorporate his high expectations for a broad label and reflect niraparib's transformation to a commercial stage asset. The analyst notes that the "strong data" from niraparib's NOVA trial, along with the lack of an expected FDA panel, should result in a broad label in the second-line or greater ovarian cancer maintenance setting, while ongoing niraparib trials in breast cancer and front-line ovarian cancer maintenance and the company's IO platform should be additional potential drivers of upside for the stock. Fernandez sees TESARO as an "attractive takeout target," and reiterates an Outperform rating on the shares.
01/10/17
LEER
01/10/17
NO CHANGE
LEER
Outperform
ARIAD acquisition supports potential takeout premium for TESARO, says Leerink
Leerink analyst Seamus Fernandez says the acquisition of ARIAD (ARIA) by Takeda (TKPYY) for $24 per share appears to be relatively in-line with other commercial stage acquisitions, and supports a potential acquisition price for TESARO (TSRO) of greater than $170 per share based on consensus forecasts. While TESARO remains well positioned to grow independently, the analyst believes a validated PARP inhibitor like niraparib could offer a durable and strategically important product opportunity for multiple suitors. He reiterates an Outperform rating on TESARO's shares.

TODAY'S FREE FLY STORIES

KFY

Korn/Ferry

$31.27

0.42 (1.36%)

20:27
03/28/17
03/28
20:27
03/28/17
20:27
Conference/Events
Korn/Ferry management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

  • 30

    Mar

EEFT

Euronet

$84.38

0.57 (0.68%)

20:25
03/28/17
03/28
20:25
03/28/17
20:25
Conference/Events
Euronet management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

PAYX

Paychex

$60.58

-0.31 (-0.51%)

, UNF

UniFirst

$136.05

0.65 (0.48%)

20:25
03/28/17
03/28
20:25
03/28/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PAYX

Paychex

$60.58

-0.31 (-0.51%)

UNF

UniFirst

$136.05

0.65 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

  • 12

    Apr

MGI

MoneyGram

$16.98

0.23 (1.37%)

, EEFT

Euronet

$84.38

0.57 (0.68%)

20:05
03/28/17
03/28
20:05
03/28/17
20:05
Periodicals
Euronet urges U.S. scrutiny of MoneyGram-Ant Financial deal, Reuters says »

Euronet (EEFT) has issued…

MGI

MoneyGram

$16.98

0.23 (1.37%)

EEFT

Euronet

$84.38

0.57 (0.68%)

BABA

Alibaba

$107.80

-0.28 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

PPG

PPG

$104.97

1.15 (1.11%)

, AKZOY

AkzoNobel

$28.04

-0.34 (-1.20%)

20:02
03/28/17
03/28
20:02
03/28/17
20:02
Periodicals
AkzoNobel holders push for talks with PPG, FT says »

Investors holding nearly…

PPG

PPG

$104.97

1.15 (1.11%)

AKZOY

AkzoNobel

$28.04

-0.34 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

19:58
03/28/17
03/28
19:58
03/28/17
19:58
Periodicals
Trump to be briefed Thursday on tax overhaul options, Bloomberg says »

President Donald Trump…

F

Ford

$11.65

0.19 (1.66%)

19:45
03/28/17
03/28
19:45
03/28/17
19:45
Conference/Events
Ford management to meet with JPMorgan »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 28

    Mar

  • 03

    Apr

  • 27

    Apr

VZ

Verizon

$49.30

0.16 (0.33%)

, CMCSA

Comcast

$37.09

-0.02 (-0.05%)

19:26
03/28/17
03/28
19:26
03/28/17
19:26
Hot Stocks
House joins Senate in passing roll-back of ISP data privacy rules »

Resolution S.J. 34 has…

VZ

Verizon

$49.30

0.16 (0.33%)

CMCSA

Comcast

$37.09

-0.02 (-0.05%)

CMCSK

Comcast

T

AT&T

$41.56

0.07 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

  • 09

    May

TSLA

Tesla

$277.45

7.23 (2.68%)

19:09
03/28/17
03/28
19:09
03/28/17
19:09
Periodicals
Tesla allegedly in Autopilot mode bumps police motorcycle, azcentral says »

A Tesla Model X had a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

TRP

TransCanada

$46.57

-0.07 (-0.15%)

19:05
03/28/17
03/28
19:05
03/28/17
19:05
Periodicals
TransCanada COO Alex Pourbaix to retire in May, Reuters reports »

TransCanada COO Alex…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSBC

HSBC

$41.05

0.36 (0.88%)

19:03
03/28/17
03/28
19:03
03/28/17
19:03
Periodicals
HSBC weighs raising as much as $1B for private credit fund, Bloomberg says »

HSBC's asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Apr

AMZN

Amazon.com

$856.00

9.18 (1.08%)

, EBAY

eBay

$33.53

0.1 (0.30%)

18:55
03/28/17
03/28
18:55
03/28/17
18:55
Hot Stocks
Barclays initiates key Internet names, sets $1,120 target on Amazon »

Barclays initiated…

AMZN

Amazon.com

$856.00

9.18 (1.08%)

EBAY

eBay

$33.53

0.1 (0.30%)

MELI

MercadoLibre

$211.51

-0.06 (-0.03%)

GOOG

Alphabet

$820.92

1.41 (0.17%)

GOOGL

Alphabet Class A

$840.63

2.12 (0.25%)

FB

Facebook

$141.76

1.44 (1.03%)

SNAP

Snap

$22.21

-1.62 (-6.80%)

TWTR

Twitter

$14.94

-0.05 (-0.33%)

GRPN

Groupon

$3.96

0.01 (0.25%)

GDDY

GoDaddy

$36.30

-0.16 (-0.44%)

SHOP

Shopify

$72.37

1.97 (2.80%)

WIX

Wix.com

$66.30

0.15 (0.23%)

WEB

Web.com

$19.30

0.15 (0.78%)

TCEHY

Tencent

$29.49

0.42 (1.44%)

BABA

Alibaba

$107.80

-0.28 (-0.26%)

BIDU

Baidu

$169.79

0.86 (0.51%)

WB

Weibo

$51.61

0.72 (1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 28

    Mar

  • 28

    Mar

  • 30

    Mar

  • 18

    Apr

  • 02

    May

  • 16

    May

  • 22

    May

  • 24

    May

VRTX

Vertex

$89.67

-1.13 (-1.24%)

18:46
03/28/17
03/28
18:46
03/28/17
18:46
Hot Stocks
Vertex up 21% after two cystic fibrosis studies show significant improvements »

In after-hours trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$11.65

0.19 (1.66%)

18:46
03/28/17
03/28
18:46
03/28/17
18:46
Hot Stocks
Ford executive chairman acquires 171,379 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 28

    Mar

  • 03

    Apr

  • 27

    Apr

RTTR

Ritter Pharmaceuticals

$1.95

-0.01 (-0.51%)

18:35
03/28/17
03/28
18:35
03/28/17
18:35
Hot Stocks
Ritter Pharmaceuticals: RP-G28 shows 'clinically meaningful benefit' in study »

Ritter Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLK

BlackRock

$380.63

5.63 (1.50%)

18:31
03/28/17
03/28
18:31
03/28/17
18:31
Hot Stocks
BlackRock to reposition equity investment platform »

BlackRock is positioning…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 12

    Apr

VRTX

Vertex

$89.67

-1.13 (-1.24%)

18:26
03/28/17
03/28
18:26
03/28/17
18:26
Hot Stocks
Vertex says two cystic fibrosis studies show significant improvements »

Vertex Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LITE

Lumentum

$54.70

0.55 (1.02%)

, VIAV

Viavi

$10.83

-0.06 (-0.55%)

18:04
03/28/17
03/28
18:04
03/28/17
18:04
Hot Stocks
AlphaOne's Dan Niles says Lumentum and Viavi are 'under the radar stocks' »

AlphaOne's Dan Niles…

LITE

Lumentum

$54.70

0.55 (1.02%)

VIAV

Viavi

$10.83

-0.06 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMST

HomeStreet

$26.70

0.2 (0.75%)

18:01
03/28/17
03/28
18:01
03/28/17
18:01
Hot Stocks
HomeStreet CFO Bartels to leave company effective April 23 »

HomeStreet, the parent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

CKH

Seacor

$67.35

1.83 (2.79%)

18:00
03/28/17
03/28
18:00
03/28/17
18:00
Earnings
Seacor reports Q4 EPS ($3.36), may not compare with consensus (41c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTX

Pernix Therapeutics

$4.06

-0.11 (-2.64%)

, GSK

GlaxoSmithKline

$42.41

-0.28 (-0.66%)

17:59
03/28/17
03/28
17:59
03/28/17
17:59
Hot Stocks
Pernix says continues to assess various alternatives, including M&A »

"We were pleased to…

PTX

Pernix Therapeutics

$4.06

-0.11 (-2.64%)

GSK

GlaxoSmithKline

$42.41

-0.28 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 06

    Jun

CSC

CSC

$69.07

1.02 (1.50%)

, SWN

Southwestern Energy

$7.89

0.19 (2.47%)

17:57
03/28/17
03/28
17:57
03/28/17
17:57
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P 500 indices »

S&P MidCap 400…

CSC

CSC

$69.07

1.02 (1.50%)

SWN

Southwestern Energy

$7.89

0.19 (2.47%)

HPE

HP Enterprise

$23.01

0.29 (1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 29

    Mar

  • 29

    Mar

  • 06

    Apr

  • 11

    Apr

  • 12

    Apr

  • 13

    Apr

  • 02

    May

  • 12

    Jun

GM

General Motors

$35.56

0.85 (2.45%)

17:52
03/28/17
03/28
17:52
03/28/17
17:52
Earnings
General Motors backs FY17 EPS view $6.00-$6.50, consensus $6.13 »

The company continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLR

Continental Resources

$43.39

0.75 (1.76%)

17:47
03/28/17
03/28
17:47
03/28/17
17:47
Hot Stocks
Continental Resources CEO acquires 41,998 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNET

RigNet

$19.70

-0.2 (-1.01%)

17:39
03/28/17
03/28
17:39
03/28/17
17:39
Hot Stocks
RigNet to provide 4G broadband in Gulf of Mexico deep waters »

RigNet continues its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.